Iranian Red Crescent Medical Journal

Published by: Kowsar

Molecular Epidemiology of Kaposi’s Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014

Khashayar Hesamizadeh 1 , 2 , Hossein Keyvani 1 , Farah Bokharaei-Salim 1 , 3 , Seyed Hamidreza Monavari 1 , Maryam Esghaei 1 , * and Fatemeh Jahanbakhsh Sefidi 4
Authors Information
1 Department of Virology, Iran University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases (MELD) Center, Tehran, IR Iran
3 HIV Laboratory of National Center, Deputy of Health, Iran University of Medical Sciences, Tehran, IR Iran
4 Department of Virology, Pasteur Institute of Iran, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: November 2016, 18 (11); e59048
  • Published Online: June 19, 2016
  • Article Type: Research Article
  • Received: August 23, 2015
  • Revised: October 26, 2015
  • Accepted: November 24, 2015
  • DOI: 10.5812/ircmj.32603

To Cite: Hesamizadeh K, Keyvani H, Bokharaei-Salim F, Monavari S H, Esghaei M, et al. Molecular Epidemiology of Kaposi’s Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014, Iran Red Crescent Med J. 2016 ; 18(11):e59048. doi: 10.5812/ircmj.32603.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192): 1865-9[PubMed]
  • 2. Klepfish A, Zuckermann B, Schattner A. Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management. QJM. 2015; 108(6): 481-8[DOI][PubMed]
  • 3. Carbone A, De Paoli P, Gloghini A, Vaccher E. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. Int J Cancer. 2015; 137(2): 251-61[DOI][PubMed]
  • 4. Dittmer DP, Damania B. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)--an update. Curr Opin Virol. 2013; 3(3): 238-44[DOI][PubMed]
  • 5. Gramolelli S, Schulz TF. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma. J Pathol. 2015; 235(2): 368-80[DOI][PubMed]
  • 6. Pica F, Volpi A. Transmission of human herpesvirus 8: an update. Curr Opin Infect Dis. 2007; 20(2): 152-6[DOI][PubMed]
  • 7. Bagni R, Whitby D. Kaposi's sarcoma-associated herpesvirus transmission and primary infection. Curr Opin HIV AIDS. 2009; 4(1): 22-6[DOI][PubMed]
  • 8. Minhas V, Wood C. Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus. Viruses. 2014; 6(11): 4178-94[DOI][PubMed]
  • 9. Jaffe HW, De Stavola BL, Carpenter LM, Porter K, Cox DR, Cascade Collaboration . Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults. AIDS. 2011; 25(11): 1395-403[DOI][PubMed]
  • 10. Cavallin LE, Goldschmidt-Clermont P, Mesri EA. Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS. PLoS Pathog. 2014; 10(7)[DOI][PubMed]
  • 11. La Ferla L, Pinzone MR, Nunnari G, Martellotta F, Lleshi A, Tirelli U, et al. Kaposi' s sarcoma in HIV-positive patients: the state of art in the HAART-era. Eur Rev Med Pharmacol Sci. 2013; 17(17): 2354-65[PubMed]
  • 12. Wang J, Liu S, Cao Y, Yang L, Chen Y, Minhas V, et al. Prevalence of Kaposi's sarcoma associated herpesvirus among men attending sexually transmitted infections clinics in Anhui, China. J Med Virol. 2016; 88(2): 304-11[DOI][PubMed]
  • 13. Uldrick TS, Whitby D. Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett. 2011; 305(2): 150-62[DOI][PubMed]
  • 14. Krown SE. Management of AIDS-Related Kaposi Sarcoma. Cancers in People with HIV and AIDS. 2014; : 139-52
  • 15. Labo N, Miley W, Benson CA, Campbell TB, Whitby D. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy. AIDS. 2015; 29(10): 1217-25[DOI][PubMed]
  • 16. Olp LN, Minhas V, Gondwe C, Kankasa C, Wojcicki J, Mitchell C, et al. Effects of Antiretroviral Therapy on Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Transmission Among HIV-Infected Zambian Children. J Natl Cancer Inst. 2015; 107(10)[DOI][PubMed]
  • 17. Keyvani H, Bokharaei-Salim F, Monavari SH, Esghaei M, Nassiri Toosi M, Fakhim S, et al. Occult hepatitis C virus infection in candidates for liver transplant with cryptogenic cirrhosis. Hepat Mon. 2013; 13(8)[DOI][PubMed]
  • 18. Ghane M, Eghbali M. Polymerase chain reaction for detection of Kaposi’s sarcoma virus in breast tumors. J Paramed Sci. 2015; 6(2)
  • 19. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. 1989; 2
  • 20. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science. 1988; 239(4839): 487-91[PubMed]
  • 21. Albrecht D, Meyer T, Lorenzen T, Stoehr A, Arndt R, Plettenberg A. Epidemiology of HHV-8 infection in HIV-positive patients with and without Kaposi sarcoma: diagnostic relevance of serology and PCR. J Clin Virol. 2004; 30(2): 145-9[DOI][PubMed]
  • 22. Martro E, Esteve A, Schulz TF, Sheldon J, Gambus G, Munoz R, et al. Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study. Int J Cancer. 2007; 120(5): 1129-35[DOI][PubMed]
  • 23. Alavi SM, Moradzadegan H, Khoshkhoy MM. Seroprevalence of HIV in Newly Detected Pulmonary Tuberculosis Patients in Khuzestan, Iran: Should HIV Testing Be Included in National Tuberculosis Program in This Region? Jundishapur J Microbiol. 2013; 6(2): 193-6
  • 24. Shushtari ZJ, Sajjadi H, Forouzan AS, Salimi Y, Dejman M. Disclosure of HIV status and social support among people living with HIV. Iran Red Crescent Med J. 2014; 16(8)[DOI]
  • 25. Bokharaei-Salim F, Keyvani H, Esghaei M, Zare S, et al. Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection. J Med Virol. 2016; [DOI]
  • 26. Hesamizadeh K, Sharafi H, Rezaee-Zavareh MS, Behnava B, Alavian SM. Next steps toward eradication of hepatitis C in the era of direct acting antivirals. Hepat Mon. 2016; 16(4)[DOI]
  • 27. Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer. 2011; 6: 5[DOI][PubMed]
  • 28. Meidani M, Aminzadeh Z, Faghih M, Ahmadi N. Are the preventive services for HHV-8 necessary in HIV positive persons in central zone of Iran? Iran J Pathol. 2014; 9(2): 133-7
  • 29. Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS. 2003; 17(12): 1717-30
  • 30. Karli B, Onel M, Eraksoy H, Agacfidan A. [Investigation of HHV-8 prevalence in anti-HIV-1 positive patients in Istanbul, Turkey]. Mikrobiyol Bul. 2013; 47(3): 493-9[PubMed]
  • 31. Szalai E, Gerlei Z, Szlavik J, Szladek G, Patel R, Hunyadi J, et al. Prevalence of human herpesvirus-8 infection in HIV-positive patients with and without Kaposi's sarcoma in Hungary. FEMS Immunol Med Microbiol. 2005; 43(2): 265-8[DOI][PubMed]
  • 32. Renwick N, Dukers NH, Weverling GJ, Sheldon JA, Schulz TF, Prins M, et al. Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996. J Infect Dis. 2002; 185(12): 1808-12[DOI][PubMed]
  • 33. National Center for HIV, STD, and TB Prevention, Division of HIV/AIDS Prevention. 2014;
  • 34. Perkins EL, Stennis KB, Taylor Spriggs V, Kwegyir-Afful EA, Prather A. Is Knowledge Enough? Considering HIV/AIDS Risk Behaviors and HIV/AIDS Knowledge with African American Women. Int J High Risk Behav Addict. 2014; 3(3)[DOI][PubMed]
  • 35. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS Med. 2014; 11(6)[DOI][PubMed]
  • 36. Plancoulaine S, Abel L, van Beveren M, Tregouet DA, Joubert M, Tortevoye P, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet. 2000; 356(9235): 1062-5[DOI][PubMed]
  • 37. Brayfield BP, Kankasa C, West JT, Muyanga J, Bhat G, Klaskala W, et al. Distribution of Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 in maternal saliva and breast milk in Zambia: implications for transmission. J Infect Dis. 2004; 189(12): 2260-70[DOI][PubMed]
  • 38. Crabtree KL, Wojcicki JM, Minhas V, Smith DR, Kankasa C, Mitchell CD, et al. Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices. Cancer Epidemiol Biomarkers Prev. 2014; 23(2): 300-8[DOI][PubMed]
  • 39. Zong J, Ciufo DM, Viscidi R, Alagiozoglou L, Tyring S, Rady P, et al. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol. 2002; 23(3): 119-48[PubMed]
  • 40. Hosseini-Moghaddam SM, Keyvani H, Soleimanirahbar A, Karimi G, Daneshvar S, Basiri A, et al. The frequency of HHV-8 infection in otherwise healthy blood donors as well as renal allograft recipients living in Iran. Arch Iran Med. 2013; 16(7): 376-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments